Around 10 million people globally live with the life-threatening virus HTLV-1, yet it remains a poorly understood disease with preventative treatments or cure. A landmark study co-led by Australian researchers could change this, after finding existing HIV drugs can suppress transmission of the HTLV-1 virus in mice.The research could lead to the first treatments to prevent the spread of this virus that is endemic among many First Nations communities around the world.

Bioengineers at Harvard have developed a new computational model that combines brain anatomy, fluid flow, and biomolecular transport dynamics to simulate brain shunt performance with pinpoint accuracy. Their goal: help with the creation of custom shunts that are tailored to specific patients’ anatomy and needs.

Long COVID patients with abnormal cardiopulmonary PET/MR findings may be more likely to develop heart and lung diseases, according to new research published in the July issue of The Journal of Nuclear Medicine. The study—which included the largest cohort of long COVID subjects with cardiopulmonary symptoms with the longest follow-up duration—suggests that abnormal cardiopulmonary PET/MR should be considered a risk factor for future cardiac and pulmonary disease and that closer monitoring is warranted in these patients.